Status:
COMPLETED
Cyberdyne HAL, TecnoBody D-Wall, and Walker View 3.0 SCX Combined Treatment
Lead Sponsor:
Ankara Yildirim Beyazıt University
Conditions:
Mosaicplasty
Cyberdyne
Eligibility:
MALE
33-33 years
Phase:
NA
Brief Summary
Mosaicplasty is a procedure where grafts taken from almost non-load-bearing areas of the joint are used to reconstruct lesioned areas. Hangody and his team developed this method using small cylindrica...
Eligibility Criteria
Inclusion
- Male patient aged 33 years.
- Body weight of 70 kg and height of 180 cm.
- Underwent knee mosaicplasty surgery on the right knee in November 2023.
- Presence of postoperative complications, including affected gait, reduced range of motion (ROM) in the knee joint, and edema.
- Ability to participate in intensive rehabilitation sessions (5 days a week, 2 hours per day) for 3 months.
Exclusion
- Patients with severe cardiovascular, pulmonary, or neurological disorders that could affect participation in the rehabilitation program.
- Presence of any other musculoskeletal conditions that could interfere with the study outcomes.
- Patients with uncontrolled metabolic disorders such as diabetes.
- Inability to follow the prescribed rehabilitation protocol due to personal or logistical reasons.
- Participation in any other physical therapy or rehabilitation program during the study period.
Key Trial Info
Start Date :
May 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06516380
Start Date
May 30 2024
End Date
June 30 2024
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Ankara, Etlik, Turkey (Türkiye), 06010